Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 17

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 17
---
 give any information or to make any representations other than those contained in this prospectus, and, if given or made, such information
or representations must not be relied upon as having been authorized by us. This prospectus does not constitute an offer to buy any security
other than the securities offered by this prospectus, or an offer to sell or a solicitation of an offer to buy any securities by any person
in any jurisdiction where such offer or solicitation is not authorized or is unlawful. Neither delivery of this prospectus nor any sale
hereunder shall, under any circumstances, create any implication that there has been no change in the affairs of our company since the
date hereof.

<div align='center'>8

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>

Item 3. Incorporation of Documents by Reference.

The Securities and Exchange Commission, or SEC,
allows us to incorporate by reference certain of our publicly filed documents into this prospectus, which means that such information
is considered part of this prospectus. Information that we file with the SEC subsequent to the date of this prospectus will automatically
update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC
under all documents subsequently filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until the selling stockholders
have sold all of the shares offered hereby or such shares have been deregistered.

| ● | The                                                                                                                       
 description of our common stock contained in our Registration Statement on Form                                           
 8-A filed with the SEC on February 1, 2019 (File                                                                          
 No. 001-38793), including any amendment or report filed for the purpose of updating such description. In addition, a Form 
 8-A filed on December 30, 2020, contains a description                                                                    
 of certain rights attributable to the common stock.                                                                       |

Notwithstanding the foregoing, information furnished under Items 2.02
and 7.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated by reference in this Registration Statement.
The information about us contained in this reoffer prospectus should be read together with the information in the documents incorporated
by reference. You may request a copy of any or all of these filings, at no cost, by writing or telephoning us at: David Moss, INmune Bio
Inc., 225